Search

Search results

496 results found

AI in Healthcare

Page

Artificial Intelligence in Healthcare Frameworks for AI Evaluation and Governance This research focuses on integrating AI in healthcare with an emphasis on ethical considerations and best practices. The goal is to ensure that AI systems are designed to promote health equity and improve patient...

Adeel Seyal, MD, and Edgar Martinez, MD, Selected to Receive 2025 HMS Shore Fellowship Awards

News: June 12, 2025

Adeel Seyal, MD, (Mentor: Olga Brook, MD) and Edgar Martinez, MD, (Mentor: David Hackney, MD), have each been awarded a prestigious 2025 Harvard Medical School Shore Fellowship Award. The fellowship is part of The Eleanor and Miles Shore Faculty Development Awards Program at Harvard Medical School...

Utilization and spending on lipid lowering therapies in Medicaid from 2018 to 2022

Publication: Journal Article

Beschloss, Alexander, Rishi K Wadhera, and Andrew S Oseran. 2025. “Utilization and Spending on Lipid Lowering Therapies in Medicaid from 2018 to 2022”. American Heart Journal.

Cardiotoxicity of combined pegylated liposomal doxorubicin and bevacizumab therapy: a propensity-matched cohort study and disproportionality analysis

Publication: Journal Article

Hoeger, Christopher W, Arrush Choudhary, Andrea Nathalie Rosas Diaz, Theresa Pinto, Sarah Smalec, Charles Doladille, Rishi K. Wadhera, et al. 2025. “Cardiotoxicity of Combined Pegylated Liposomal Doxorubicin and Bevacizumab Therapy: A Propensity-Matched Cohort Study and Disproportionality Analysis”. BMC Cardio-Oncology.

Targeted delivery of IL-21 neutralizing nanotherapeutics to lymph nodes and kidney allografts attenuates B cell alloimmunity.

Publication: Journal Article

Zhang, Hengcheng, Gianmarco Sabiu, Sungwook Jung, Manuel A Podestà, Jing Zhao, Maya Gempler, Minako Yamamura, et al. 2025. “Targeted Delivery of IL-21 Neutralizing Nanotherapeutics to Lymph Nodes and Kidney Allografts Attenuates B Cell Alloimmunity.”. Kidney International 108 (1): 48-56.

Introducing Dr. Arpita Kulkarni, Co-Director, Functional Genomics and Bioinformatics Core!

News: July 14, 2025

We’re thrilled to welcome Dr. Arpita Kulkarni to BIDMC as Co-Director of the Functional Genomics and Bioinformatics Core. With deep expertise in single-cell biology, genomic technologies, and translational science, Arpita brings a strong track record of bridging cutting-edge omics platforms with...

Search

Search results

AI in Healthcare

Adeel Seyal, MD, and Edgar Martinez, MD, Selected to Receive 2025 HMS Shore Fellowship Awards

Utilization and spending on lipid lowering therapies in Medicaid from 2018 to 2022

Cardiotoxicity of combined pegylated liposomal doxorubicin and bevacizumab therapy: a propensity-matched cohort study and disproportionality analysis

Targeted delivery of IL-21 neutralizing nanotherapeutics to lymph nodes and kidney allografts attenuates B cell alloimmunity.

Introducing Dr. Arpita Kulkarni, Co-Director, Functional Genomics and Bioinformatics Core!

Simultaneous Inhibition of PARP/AKT to Intercept Nascent BRCA1/2mut Breast Tumors

Measuring Success in Renal Denervation: Response Parameters and Predictors of Response.

Fellow Spotlight: Azariah Boyd

Comparable Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants.